Aytu BioPharma, Inc. (AYTU)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$2.52
-1.56%
Mkt Cap $21.14M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 3, 2026 | $12.17M | $15.20M | +24.85% | -$0.26 | -$1.05 | -303.85% | — | — |
| Q4 2025 Nov 13, 2025 | $12.60M | $13.89M | +10.24% | -$0.06 | -$0.08 | -33.33% | — | — |
| Q3 2025 Sep 23, 2025 | $17.92M | $15.13M | -15.55% | -$0.02 | -$0.26 | -1200.00% | — | — |
| Q2 2025 May 14, 2025 | $18.83M | $18.45M | -2.02% | -$0.17 | $0.20 | +217.65% | — | — |
| Q1 2025 Feb 12, 2025 | $17.59M | $16.22M | -7.77% | -$0.28 | -$0.28 | +0.00% | — | — |
| Q4 2024 Nov 13, 2024 | $13.77M | $16.57M | +20.36% | -$0.34 | -$0.20 | +41.18% | — | — |
| Q3 2024 Sep 26, 2024 | $18.30M | $17.98M | -1.77% | -$0.45 | -$0.82 | -82.22% | — | — |
| Q2 2024 May 15, 2024 | $18.30M | $17.99M | -1.68% | -$0.64 | -$0.52 | +18.75% | — | — |
| Q1 2024 Feb 14, 2024 | $21.74M | $22.93M | +5.49% | -$0.25 | -$0.04 | +84.00% | — | — |
| Q4 2023 Nov 14, 2023 | $27.73M | $22.10M | -20.31% | -$0.04 | -$1.48 | -3600.00% | — | — |
| Q3 2023 Sep 27, 2023 | $27.69M | $30.73M | +10.99% | -$0.95 | $0.16 | +116.84% | — | — |
| Q2 2023 May 11, 2023 | $26.10M | $22.73M | -12.90% | -$0.63 | -$1.93 | -206.35% | — | — |
| Q1 2023 Feb 21, 2023 | $29.50M | $26.28M | -10.92% | $0.20 | -$1.31 | -755.00% | — | — |
| Q4 2022 Nov 14, 2022 | $24.30M | $27.66M | +13.81% | -$3.60 | -$1.20 | +66.67% | — | — |
| Q3 2022 Sep 27, 2022 | $25.70M | $27.45M | +6.80% | -$4.80 | -$5.00 | -4.17% | — | — |
| Q2 2022 May 16, 2022 | $24.20M | $24.20M | -0.00% | -$8.20 | -$5.40 | +34.15% | — | — |
| Q1 2022 Feb 14, 2022 | $23.10M | $23.13M | +0.11% | -$7.09 | -$8.80 | -24.14% | — | — |
| Q4 2021 Nov 15, 2021 | $18.25M | $21.90M | +19.99% | -$2.97 | -$6.60 | -122.45% | — | — |
| Q3 2021 Sep 27, 2021 | — | $23.48M | — | -$3.20 | -$13.40 | -318.75% | — | — |
| Q2 2021 May 17, 2021 | $14.68M | $13.48M | -8.16% | -$7.20 | -$3.40 | +52.78% | — | — |